Table 1.
Characteristics of patients enrolled in this study (age, body mass index, and menopause).
| Age | Median−58 (range: 35–87) |
| Body mass index (BMI) | Median−26.03 (range: 17.04–39.74) |
| Post-menopause | 62.30% |
| ER+ (PR –/+) | 68% |
| HER2+ including triple positive breast cancer | 16% |
| TNBC | 16% |
| Grade | G1–8.26% |
| G2–58.68% | |
| G3–33.06% | |
| Ki67 | Median−21.75% (range: 2–98.4%) |
| Dimension (mm) | Median−25 (range: 7–90) |
| Axillary lymph node invasion status | Negative−51.09% |
| Positive−48.91% | |
| Response (if NACT) | Good response−43.33% |
| Bad response−56.67% |
Clinical data, such as subtype of breast cancer, grade, Ki67, tumor dimension, node status and response to treatment are also described.